I have today participated in a meeting jointly organized by LIF (the research based pharmaceutical industry in Sweden) and patient associations in Gävleborg (HSO Gävleborg) up in Gävle. A very good and interesting meeting where we discussed issues ranging from the work tasks for the pharmaceutical committee in Gävleborg, consequences of the pharmacy de-/re-regulation in Sweden, the Swedish drug insurance scheme, the product of the month (and other aspects of the generic reform), and pharmaceuticals and the environment. The latter topic was of course my contribution to the agenda of today.
The discussion was intense, and the issue of mandatory generic substitution at the pharmacy desk – to the “product of the month”, potentially from a company not participating in the Swedish drug insurance scheme, and/or a pharmaceutical product being anything but “green” – is no doubt a hot topic!
The title of my presentation was “Pharmaceuticals and the Environment – when will we be able to choose green pharmaceuticals?” You know that I have great hopes for the coming year regarding the development of a pricing and reimbursement system allowing for green economic incentives to green pharmaceuticals. If you like to dig into some details on the topic of green pharmaceuticals and green incentives (including discussions on Sofia Wallström's review, on the All Party Committee on Environmental Objectives, and on MPA's proposal to add environmental requirements to GMP) just follow the links...
Thanks to LIF and HSO Gävleborg for arranging the meeting today. I really like it when the debate is intense! It was both interesting and fun!